Medical countermeasure drug discovery & development increment 3
Ended Awarded Last action
- Contract number
- FA460023F0086
- Awardee
-
National Strategic Research Institute UEI CZLHXAXKJYX1
- Awarding agency
-
Air Combat Command
Air Force, Department of Defense
- Obligated
- $10,746,999
Award facts
- Contract value 44% obligated
-
- $16,194,985.00 Current, with exercised options
- $24,500,150.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Offutt AFB, NE 68113, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $1,308,000 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $6,310,999 | |
| Change Order | $0 | |
| Original award | $3,128,000 |
About this award
The Defense Health Agency issued a $24.5 million delivery order to National Strategic Research Institute on September 1, 2023, for medical countermeasure drug discovery and development (Increment 3) supporting the U.S. Army Medical Research and Development Command and the Defense Health Agency through August 31, 2028.
Place of performance is Offutt Air Force Base, Nebraska. The order is priced on a cost-plus-fixed-fee basis with no set-aside designation.
National Strategic Research Institute is a non-profit research organization affiliated with the University of Nebraska System. The delivery order engages a multi-institutional research team including the University of Nebraska Medical Center, the University of Nebraska Office of Sponsored Programs, and the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., each contributing specialized medical research and development capabilities to the countermeasure development effort across multiple sub-awards issued between September 2023 and October 2025.
Subawards
Show all 16
Quick answers
Who was awarded contract FA460023F0086?
FA460023F0086 was awarded to National Strategic Research Institute by Air Combat Command (Air Force) on September 1, 2023.
How much is contract FA460023F0086 worth?
The government has obligated $10,746,999 on FA460023F0086. Its current value, with exercised options, is $16,194,985. Its potential value, with all options, is $24,500,150.
Which agency awarded contract FA460023F0086?
Air Combat Command (Air Force) awarded FA460023F0086, with funding from Defense Health Agency (Department of Defense).
Is contract FA460023F0086 an order under another contract?
Yes. FA460023F0086 is a delivery order under FA460020D0003, an indefinite delivery contract.
Was contract FA460023F0086 competed?
The extent of competition for FA460023F0086 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award